top of page
gradientForSurfBreak.png

Item List

Buesinesswire
COMPaSS™ Personalized Spine Surgery Study Begins Enrollment

Carlsmed® announced today that the first patients have been enrolled in the COMPaSS™ study. COMPaSS, Clinical Outcome Measures in Personalized aprevo® Spine Surgery, is a multi-center post market prospective observational registry. The study will collect data on patients with degenerative spinal conditions and are treated surgically with Carlsmed aprevo devices and will track outcomes for a period of two years.

Recent Posts

Portfolio Company

Carlsmed.png

Marigold Health Secures $11m in Series A Funding to Expand Peer Support
...

Busineswire

Portfolio Company

Carlsmed.png

Materna Medical Launches Groundbreaking Virtual Clinical Trial Evaluating Treatm ...

Yahoo Finance

Portfolio Company

Carlsmed.png


Clarified Precision Medicine, xCures Partner to Improve Clinical Decision Suppo ...

Precision Medicine Online

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page